Both in Pharmaceuticals
uniQure vs Kailera Therapeutics
Over the past year QURE returned −48.5% and KLRA returned −9.4%; their daily moves had a correlation of 0.26.
QURE −48.5% KLRA −9.4%Growth of $1, one year, split-adjusted
| Metric | QURE | KLRA |
|---|---|---|
| Price | $22.93 | $12.63 |
| Market cap | $1.59B | $1.64B |
| Today | −3.94% | +0.40% |
| 1 month | −0.6% | +16.6% |
| 6 months | +0.5% | — |
| Year to date | −4.2% | — |
| 1 year | −33.1% | — |
| Revenue growth (YoY) | +11.0% | — |
| Gross margin | 94.0% | — |
| Net margin | −1387.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 85.2× | — |
| Net cash | $760.2M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 109.2% | — |
| Short % of float | 13.2% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).